Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

FDG positron emission tomography/computed tomography studies of Wilms' tumor.

Moinul Hossain AK, Shulkin BL, Gelfand MJ, Bashir H, Daw NC, Sharp SE, Nadel HR, Dome JS.

Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1300-8. doi: 10.1007/s00259-010-1396-2. Epub 2010 Mar 4.

2.

Pilot study of F(18)-Fluorodeoxyglucose Positron Emission Tomography/computerised tomography in Wilms' tumour: correlation with conventional imaging, pathology and immunohistochemistry.

Begent J, Sebire NJ, Levitt G, Brock P, Jones KP, Ell P, Gordon I, Anderson J.

Eur J Cancer. 2011 Feb;47(3):389-96. doi: 10.1016/j.ejca.2010.09.039. Epub 2010 Nov 10.

PMID:
21074411
3.

FDG PET/CT imaging of desmoplastic small round cell tumor: findings at staging, during treatment and at follow-up.

Ostermeier A, McCarville MB, Navid F, Snyder SE, Shulkin BL.

Pediatr Radiol. 2015 Aug;45(9):1308-15. doi: 10.1007/s00247-015-3315-y. Epub 2015 Feb 27.

4.

Is there a role for FDG-PET for the assessment of treatment efficacy in Wilms' tumor? A case report and literature review.

Provenzi M, Saettini F, Conter V, Chinaglia D, Vai P, Bruno A, Cavalleri L, Foglia C, Giraldi E, Collini P, Spreafico F.

Pediatr Hematol Oncol. 2013 Oct;30(7):633-9. doi: 10.3109/08880018.2013.832446. Review.

PMID:
24050763
5.

Monitoring therapy with MEK inhibitor U0126 in a novel Wilms tumor model in Wt1 knockout Igf2 transgenic mice using 18F-FDG PET with dual-contrast enhanced CT and MRI: early metabolic response without inhibition of tumor growth.

Flores LG 2nd, Yeh HH, Soghomonyan S, Young D, Bankson J, Hu Q, Alauddin M, Huff V, Gelovani JG.

Mol Imaging Biol. 2013 Apr;15(2):175-85. doi: 10.1007/s11307-012-0588-5.

6.

PET FDG studies of Wilms tumors.

Shulkin BL, Chang E, Strouse PJ, Bloom DA, Hutchinson RJ.

J Pediatr Hematol Oncol. 1997 Jul-Aug;19(4):334-8.

PMID:
9256833
7.

Use of chest computed tomography in the staging of pediatric Wilms' tumor: interobserver variability and prognostic significance.

Wilimas JA, Kaste SC, Kauffman WM, Winer-Muram H, Morris R, Luo X, Boyett JM.

J Clin Oncol. 1997 Jul;15(7):2631-5.

PMID:
9215834
8.

Use of positron emission tomography for staging, preoperative response assessment and posttherapeutic evaluation in children with Wilms tumour.

Misch D, Steffen IG, Schönberger S, Voelker T, Furth C, Stöver B, Hautzel H, Henze G, Amthauer H, Denecke T.

Eur J Nucl Med Mol Imaging. 2008 Sep;35(9):1642-50. doi: 10.1007/s00259-008-0819-9. Epub 2008 May 29.

PMID:
18509634
9.

Role of chest computed tomography at diagnosis in the management of Wilms' tumor: a study by the United Kingdom Children's Cancer Study Group.

Owens CM, Veys PA, Pritchard J, Levitt G, Imeson J, Dicks-Mireaux C.

J Clin Oncol. 2002 Jun 15;20(12):2768-73.

PMID:
12065552
10.

Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.

Arush MW, Israel O, Postovsky S, Militianu D, Meller I, Zaidman I, Sapir AE, Bar-Shalom R.

Pediatr Blood Cancer. 2007 Dec;49(7):901-5.

PMID:
17252575
11.

Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.

Ak I, Sivrikoz MC, Entok E, Vardareli E.

Eur J Cardiothorac Surg. 2010 Apr;37(4):792-6. doi: 10.1016/j.ejcts.2009.11.011. Epub 2009 Dec 16.

PMID:
20015657
12.
13.

Local staging of Wilms' tumor--computerized tomography correlation with histological findings.

Gow KW, Roberts IF, Jamieson DH, Bray H, Magee JF, Murphy JJ.

J Pediatr Surg. 2000 May;35(5):677-9.

PMID:
10813321
14.

18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.

Singnurkar A, Solomon SB, Gönen M, Larson SM, Schöder H.

J Nucl Med. 2010 Dec;51(12):1833-40. doi: 10.2967/jnumed.110.076778. Epub 2010 Nov 15. Erratum in: J Nucl Med. 2011 Jan;52(1):106.

15.

Comparison of bone and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer.

Gayed I, Vu T, Johnson M, Macapinlac H, Podoloff D.

Mol Imaging Biol. 2003 Jan-Feb;5(1):26-31.

PMID:
14499159
16.

Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma.

Graafland NM, Leijte JA, Valdés Olmos RA, Hoefnagel CA, Teertstra HJ, Horenblas S.

Eur Urol. 2009 Aug;56(2):339-45. doi: 10.1016/j.eururo.2009.05.016. Epub 2009 May 19.

PMID:
19477581
17.
18.

90Y microsphere treatment of unresectable liver metastases: changes in 18F-FDG uptake and tumour size on PET/CT.

Bienert M, McCook B, Carr BI, Geller DA, Sheetz M, Tutor C, Amesur N, Avril N.

Eur J Nucl Med Mol Imaging. 2005 Jul;32(7):778-87. Epub 2005 Mar 17.

PMID:
15772860
19.

Significance of pulmonary computed tomography at diagnosis in Wilms' tumor.

Wilimas JA, Douglass EC, Magill HL, Fitch S, Hustu HO.

J Clin Oncol. 1988 Jul;6(7):1144-6.

PMID:
2839631
20.

The value of surgery in directing therapy for patients with Wilms' tumor with pulmonary disease. A report from the National Wilms' Tumor Study Group (National Wilms' Tumor Study 5).

Ehrlich PF, Hamilton TE, Grundy P, Ritchey M, Haase G, Shamberger RC; National Wilms' Tumor Study Group (National Wilms' Tumor Study 5).

J Pediatr Surg. 2006 Jan;41(1):162-7; discussion 162-7.

PMID:
16410127

Supplemental Content

Support Center